| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Influenza A virus | 11 | 2025 | 116 | 3.300 |
Why?
|
| Influenza, Human | 14 | 2025 | 192 | 2.900 |
Why?
|
| Diabetes Mellitus, Type 1 | 7 | 2025 | 605 | 2.880 |
Why?
|
| Antiviral Agents | 14 | 2024 | 313 | 2.570 |
Why?
|
| Interferon Type I | 9 | 2025 | 169 | 2.180 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 9 | 2022 | 86 | 1.860 |
Why?
|
| Islets of Langerhans | 6 | 2025 | 271 | 1.670 |
Why?
|
| Drug Resistance, Viral | 7 | 2022 | 156 | 1.470 |
Why?
|
| Oseltamivir | 6 | 2022 | 34 | 1.360 |
Why?
|
| Immunity, Innate | 9 | 2021 | 774 | 1.310 |
Why?
|
| Adenosine Monophosphate | 4 | 2024 | 27 | 1.170 |
Why?
|
| Alanine | 4 | 2024 | 49 | 1.170 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 6 | 2022 | 40 | 1.140 |
Why?
|
| Dendritic Cells | 9 | 2015 | 515 | 1.070 |
Why?
|
| Macrophages | 6 | 2021 | 1015 | 1.060 |
Why?
|
| Receptor, Interferon alpha-beta | 4 | 2025 | 45 | 1.040 |
Why?
|
| Toll-Like Receptor 7 | 5 | 2019 | 95 | 1.000 |
Why?
|
| Janus Kinase Inhibitors | 2 | 2025 | 17 | 0.980 |
Why?
|
| Neuraminidase | 4 | 2022 | 43 | 0.920 |
Why?
|
| Enterovirus B, Human | 4 | 2020 | 17 | 0.900 |
Why?
|
| Animals | 46 | 2025 | 19667 | 0.870 |
Why?
|
| RNA, Viral | 6 | 2024 | 259 | 0.850 |
Why?
|
| Host-Pathogen Interactions | 2 | 2025 | 240 | 0.840 |
Why?
|
| Toll-Like Receptors | 9 | 2011 | 426 | 0.830 |
Why?
|
| Autoimmunity | 2 | 2021 | 223 | 0.790 |
Why?
|
| Prediabetic State | 1 | 2023 | 51 | 0.780 |
Why?
|
| Cytokines | 12 | 2025 | 912 | 0.770 |
Why?
|
| Parvoviridae Infections | 1 | 2021 | 23 | 0.750 |
Why?
|
| Coxsackievirus Infections | 3 | 2020 | 12 | 0.730 |
Why?
|
| Pyrazines | 2 | 2017 | 33 | 0.680 |
Why?
|
| Amides | 2 | 2017 | 52 | 0.680 |
Why?
|
| Antibodies, Viral | 5 | 2021 | 292 | 0.660 |
Why?
|
| Dogs | 10 | 2019 | 314 | 0.660 |
Why?
|
| Membrane Glycoproteins | 7 | 2019 | 661 | 0.650 |
Why?
|
| Herpesvirus 1, Human | 4 | 2024 | 78 | 0.650 |
Why?
|
| Rats | 5 | 2025 | 1911 | 0.620 |
Why?
|
| Humans | 61 | 2025 | 59454 | 0.600 |
Why?
|
| Pyrazoles | 3 | 2025 | 65 | 0.590 |
Why?
|
| Interferon-alpha | 4 | 2014 | 99 | 0.570 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2017 | 69 | 0.570 |
Why?
|
| Pregnancy Complications, Parasitic | 1 | 2017 | 6 | 0.560 |
Why?
|
| Mice | 28 | 2024 | 10301 | 0.540 |
Why?
|
| Herpes Simplex | 4 | 2024 | 48 | 0.540 |
Why?
|
| DEAD-box RNA Helicases | 3 | 2014 | 79 | 0.530 |
Why?
|
| Genome, Viral | 2 | 2015 | 122 | 0.520 |
Why?
|
| Biological Evolution | 1 | 2017 | 114 | 0.520 |
Why?
|
| Cell Line | 12 | 2021 | 1984 | 0.510 |
Why?
|
| Viral Load | 2 | 2024 | 220 | 0.510 |
Why?
|
| Virus Replication | 5 | 2025 | 305 | 0.500 |
Why?
|
| Plasmodium falciparum | 1 | 2017 | 134 | 0.500 |
Why?
|
| Malaria, Falciparum | 1 | 2017 | 119 | 0.500 |
Why?
|
| Mutation | 5 | 2024 | 2458 | 0.480 |
Why?
|
| Islets of Langerhans Transplantation | 2 | 2019 | 174 | 0.470 |
Why?
|
| Coronavirus Infections | 3 | 2021 | 192 | 0.460 |
Why?
|
| Toll-Like Receptor 8 | 2 | 2012 | 44 | 0.460 |
Why?
|
| Evolution, Molecular | 4 | 2018 | 298 | 0.450 |
Why?
|
| Myeloid Differentiation Factor 88 | 3 | 2011 | 202 | 0.440 |
Why?
|
| Rats, Inbred Lew | 2 | 2025 | 106 | 0.440 |
Why?
|
| Hyperglycemia | 1 | 2014 | 98 | 0.440 |
Why?
|
| Male | 22 | 2025 | 27784 | 0.440 |
Why?
|
| Neutrophils | 3 | 2021 | 365 | 0.430 |
Why?
|
| Antibodies, Neutralizing | 3 | 2021 | 178 | 0.430 |
Why?
|
| Female | 23 | 2024 | 30766 | 0.410 |
Why?
|
| Imidazoles | 2 | 2012 | 77 | 0.410 |
Why?
|
| Viral Proteins | 3 | 2022 | 257 | 0.410 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2011 | 202 | 0.410 |
Why?
|
| Sialic Acids | 1 | 2013 | 36 | 0.400 |
Why?
|
| Cryptococcus neoformans | 2 | 2011 | 147 | 0.400 |
Why?
|
| Mice, Knockout | 12 | 2019 | 1997 | 0.400 |
Why?
|
| Signal Transduction | 6 | 2025 | 2901 | 0.390 |
Why?
|
| Receptors, Interleukin-18 | 1 | 2011 | 10 | 0.380 |
Why?
|
| Azetidines | 2 | 2022 | 7 | 0.380 |
Why?
|
| Double-Blind Method | 5 | 2024 | 715 | 0.380 |
Why?
|
| Adult | 15 | 2024 | 15697 | 0.380 |
Why?
|
| Purines | 2 | 2022 | 38 | 0.370 |
Why?
|
| Polysaccharides | 1 | 2013 | 140 | 0.370 |
Why?
|
| Mycobacterium tuberculosis | 3 | 2020 | 391 | 0.370 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2011 | 66 | 0.370 |
Why?
|
| Sulfonamides | 2 | 2022 | 120 | 0.350 |
Why?
|
| Aspergillosis | 3 | 2023 | 40 | 0.350 |
Why?
|
| Gene Editing | 2 | 2025 | 299 | 0.350 |
Why?
|
| Cells, Cultured | 9 | 2020 | 2095 | 0.340 |
Why?
|
| Gene Expression Regulation | 6 | 2021 | 1553 | 0.340 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 2 | 2015 | 26 | 0.330 |
Why?
|
| Mice, Inbred C57BL | 13 | 2019 | 3236 | 0.330 |
Why?
|
| Central Nervous System | 1 | 2011 | 193 | 0.330 |
Why?
|
| Parvovirus | 2 | 2021 | 24 | 0.320 |
Why?
|
| Disease Models, Animal | 5 | 2025 | 2051 | 0.320 |
Why?
|
| Blood Platelets | 2 | 2021 | 92 | 0.320 |
Why?
|
| Virus Diseases | 2 | 2007 | 114 | 0.320 |
Why?
|
| West Nile virus | 1 | 2009 | 8 | 0.320 |
Why?
|
| Receptors, Cell Surface | 4 | 2008 | 428 | 0.320 |
Why?
|
| Biomarkers | 1 | 2024 | 1306 | 0.310 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 205 | 0.310 |
Why?
|
| Oligodeoxyribonucleotides | 3 | 2008 | 243 | 0.310 |
Why?
|
| Inflammation | 4 | 2023 | 1099 | 0.290 |
Why?
|
| A549 Cells | 2 | 2025 | 36 | 0.280 |
Why?
|
| Blood Component Transfusion | 1 | 2017 | 8 | 0.280 |
Why?
|
| CRISPR-Cas Systems | 2 | 2025 | 335 | 0.280 |
Why?
|
| Plasma | 1 | 2017 | 35 | 0.270 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 411 | 0.270 |
Why?
|
| Mutation Rate | 2 | 2017 | 19 | 0.270 |
Why?
|
| Cardiovirus Infections | 2 | 2019 | 14 | 0.270 |
Why?
|
| Encephalomyocarditis virus | 2 | 2019 | 15 | 0.270 |
Why?
|
| Plasma Cells | 1 | 2007 | 49 | 0.270 |
Why?
|
| Monocytes | 2 | 2005 | 345 | 0.270 |
Why?
|
| Poly I-C | 2 | 2025 | 76 | 0.260 |
Why?
|
| Madin Darby Canine Kidney Cells | 4 | 2019 | 22 | 0.260 |
Why?
|
| Dengue Virus | 1 | 2006 | 95 | 0.260 |
Why?
|
| Treatment Outcome | 6 | 2024 | 5287 | 0.250 |
Why?
|
| Herpesvirus 3, Human | 1 | 2005 | 9 | 0.250 |
Why?
|
| Genetics, Population | 2 | 2017 | 40 | 0.250 |
Why?
|
| Herpes Zoster | 1 | 2005 | 23 | 0.250 |
Why?
|
| Endosomes | 1 | 2006 | 170 | 0.250 |
Why?
|
| Listeria monocytogenes | 1 | 2005 | 33 | 0.240 |
Why?
|
| Aspergillus fumigatus | 4 | 2023 | 52 | 0.240 |
Why?
|
| Salmonella enterica | 1 | 2005 | 26 | 0.240 |
Why?
|
| Adenosine Deaminase | 1 | 2025 | 17 | 0.240 |
Why?
|
| Middle Aged | 11 | 2024 | 16335 | 0.240 |
Why?
|
| RNA | 2 | 2023 | 402 | 0.230 |
Why?
|
| Nitriles | 1 | 2025 | 62 | 0.230 |
Why?
|
| Sulfides | 1 | 2024 | 23 | 0.230 |
Why?
|
| Antitubercular Agents | 1 | 2005 | 76 | 0.230 |
Why?
|
| Deoxyribonucleotides | 1 | 2024 | 13 | 0.230 |
Why?
|
| Acetates | 1 | 2024 | 33 | 0.230 |
Why?
|
| Quinolines | 1 | 2024 | 41 | 0.230 |
Why?
|
| In Vitro Techniques | 3 | 2013 | 473 | 0.230 |
Why?
|
| Organoids | 1 | 2024 | 40 | 0.230 |
Why?
|
| Apoptosis | 2 | 2021 | 1033 | 0.230 |
Why?
|
| Cyclopropanes | 1 | 2024 | 50 | 0.230 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 2024 | 34 | 0.230 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2015 | 295 | 0.230 |
Why?
|
| Selection, Genetic | 2 | 2015 | 71 | 0.220 |
Why?
|
| Pyrimidines | 1 | 2025 | 131 | 0.220 |
Why?
|
| Administration, Intravenous | 2 | 2020 | 61 | 0.220 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2025 | 91 | 0.220 |
Why?
|
| Serine Endopeptidases | 2 | 2021 | 84 | 0.220 |
Why?
|
| Invasive Pulmonary Aspergillosis | 1 | 2023 | 5 | 0.220 |
Why?
|
| Pulmonary Aspergillosis | 1 | 2023 | 10 | 0.210 |
Why?
|
| Liposomes | 2 | 2015 | 100 | 0.210 |
Why?
|
| Oxygen | 2 | 2022 | 313 | 0.210 |
Why?
|
| Insulin-Secreting Cells | 3 | 2020 | 178 | 0.210 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 720 | 0.200 |
Why?
|
| Antigen-Antibody Complex | 3 | 2014 | 51 | 0.200 |
Why?
|
| Trans-Activators | 2 | 2020 | 300 | 0.200 |
Why?
|
| Models, Molecular | 4 | 2019 | 1128 | 0.190 |
Why?
|
| Recombinant Proteins | 4 | 2017 | 691 | 0.190 |
Why?
|
| Nasal Lavage | 1 | 2021 | 2 | 0.190 |
Why?
|
| Rats, Transgenic | 1 | 2021 | 7 | 0.190 |
Why?
|
| Interferon beta-1a | 1 | 2021 | 9 | 0.190 |
Why?
|
| RNA-Binding Proteins | 1 | 2025 | 386 | 0.190 |
Why?
|
| Chemotaxis | 1 | 2021 | 48 | 0.190 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2021 | 25 | 0.180 |
Why?
|
| Influenza Vaccines | 2 | 2021 | 91 | 0.180 |
Why?
|
| Respiratory Mucosa | 1 | 2021 | 54 | 0.180 |
Why?
|
| Transcriptome | 2 | 2024 | 341 | 0.180 |
Why?
|
| Dexamethasone | 1 | 2022 | 201 | 0.180 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2020 | 15 | 0.180 |
Why?
|
| Bursa, Synovial | 1 | 2000 | 1 | 0.180 |
Why?
|
| Sporotrichosis | 1 | 2000 | 2 | 0.180 |
Why?
|
| Sporothrix | 1 | 2000 | 3 | 0.180 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2021 | 182 | 0.170 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 446 | 0.170 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2021 | 191 | 0.170 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2020 | 7 | 0.170 |
Why?
|
| Goblet Cells | 1 | 2020 | 8 | 0.170 |
Why?
|
| Nasal Mucosa | 1 | 2020 | 18 | 0.170 |
Why?
|
| Bursitis | 1 | 2000 | 15 | 0.170 |
Why?
|
| Killer Cells, Natural | 1 | 2021 | 218 | 0.170 |
Why?
|
| Sequence Analysis, RNA | 2 | 2019 | 159 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 529 | 0.170 |
Why?
|
| Enterocytes | 1 | 2020 | 24 | 0.170 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 42 | 0.170 |
Why?
|
| Endocrine Cells | 1 | 2019 | 10 | 0.170 |
Why?
|
| Capsid Proteins | 1 | 2020 | 92 | 0.170 |
Why?
|
| Epitopes | 1 | 2021 | 286 | 0.160 |
Why?
|
| Respiration, Artificial | 3 | 2020 | 292 | 0.160 |
Why?
|
| Up-Regulation | 4 | 2020 | 365 | 0.160 |
Why?
|
| Platelet Activation | 1 | 2019 | 26 | 0.160 |
Why?
|
| Reverse Genetics | 1 | 2019 | 10 | 0.160 |
Why?
|
| Homeodomain Proteins | 1 | 2020 | 254 | 0.160 |
Why?
|
| Disease Resistance | 1 | 2019 | 23 | 0.160 |
Why?
|
| Aged | 7 | 2024 | 13424 | 0.150 |
Why?
|
| ADAM Proteins | 1 | 2019 | 34 | 0.150 |
Why?
|
| Neutralization Tests | 1 | 2019 | 118 | 0.150 |
Why?
|
| Extracellular Traps | 2 | 2019 | 41 | 0.150 |
Why?
|
| Repressor Proteins | 1 | 2020 | 331 | 0.150 |
Why?
|
| Lectins, C-Type | 3 | 2015 | 88 | 0.150 |
Why?
|
| Silent Mutation | 1 | 2018 | 5 | 0.150 |
Why?
|
| High-Throughput Screening Assays | 2 | 2021 | 74 | 0.150 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2017 | 33 | 0.150 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 681 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2020 | 396 | 0.140 |
Why?
|
| Knee Joint | 1 | 2000 | 286 | 0.140 |
Why?
|
| Genetic Fitness | 1 | 2018 | 30 | 0.140 |
Why?
|
| Enzyme Inhibitors | 2 | 2016 | 347 | 0.140 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2017 | 58 | 0.140 |
Why?
|
| Quinidine | 1 | 2017 | 2 | 0.140 |
Why?
|
| Gravidity | 1 | 2017 | 12 | 0.140 |
Why?
|
| Chloroquine | 1 | 2017 | 50 | 0.140 |
Why?
|
| Chemoprevention | 1 | 2017 | 39 | 0.140 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 648 | 0.140 |
Why?
|
| Antimalarials | 1 | 2017 | 67 | 0.130 |
Why?
|
| Species Specificity | 3 | 2007 | 329 | 0.130 |
Why?
|
| Vero Cells | 2 | 2015 | 76 | 0.130 |
Why?
|
| Brain | 1 | 2024 | 1488 | 0.130 |
Why?
|
| Pandemics | 3 | 2023 | 617 | 0.130 |
Why?
|
| Anti-Retroviral Agents | 1 | 2016 | 73 | 0.130 |
Why?
|
| Viruses | 2 | 2007 | 78 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2020 | 635 | 0.130 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 2020 | 57 | 0.130 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 191 | 0.130 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2017 | 217 | 0.120 |
Why?
|
| Hemagglutination | 2 | 2013 | 3 | 0.120 |
Why?
|
| RNA Caps | 1 | 2015 | 17 | 0.120 |
Why?
|
| Down-Regulation | 2 | 2014 | 307 | 0.120 |
Why?
|
| Recurrence | 1 | 2017 | 603 | 0.120 |
Why?
|
| Reassortant Viruses | 1 | 2015 | 9 | 0.120 |
Why?
|
| Parainfluenza Virus 3, Human | 1 | 2015 | 2 | 0.120 |
Why?
|
| Heparitin Sulfate | 1 | 2015 | 10 | 0.120 |
Why?
|
| Lung | 4 | 2023 | 920 | 0.120 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2015 | 17 | 0.120 |
Why?
|
| Simplexvirus | 1 | 2015 | 25 | 0.120 |
Why?
|
| Membrane Proteins | 2 | 2019 | 850 | 0.120 |
Why?
|
| Interferon-gamma | 3 | 2007 | 551 | 0.110 |
Why?
|
| Betacoronavirus | 2 | 2020 | 166 | 0.110 |
Why?
|
| Adolescent | 2 | 2022 | 5851 | 0.110 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 2 | 2014 | 16 | 0.110 |
Why?
|
| Plasmodium berghei | 1 | 2014 | 21 | 0.110 |
Why?
|
| Hemostatics | 1 | 2014 | 26 | 0.110 |
Why?
|
| Interferon-beta | 1 | 2014 | 76 | 0.110 |
Why?
|
| NF-kappa B | 2 | 2006 | 460 | 0.110 |
Why?
|
| Interleukin-1beta | 2 | 2014 | 258 | 0.110 |
Why?
|
| Malaria, Cerebral | 1 | 2014 | 23 | 0.110 |
Why?
|
| Antigens, Viral | 1 | 2024 | 130 | 0.110 |
Why?
|
| Respiratory Tract Infections | 2 | 2021 | 84 | 0.110 |
Why?
|
| Viral Plaque Assay | 1 | 2013 | 16 | 0.110 |
Why?
|
| Receptors, Virus | 2 | 2020 | 67 | 0.110 |
Why?
|
| DNA-Binding Proteins | 2 | 2014 | 1151 | 0.110 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2013 | 88 | 0.110 |
Why?
|
| Ribonuclease III | 1 | 2013 | 82 | 0.110 |
Why?
|
| Chitosan | 1 | 2014 | 82 | 0.110 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 234 | 0.110 |
Why?
|
| Rous sarcoma virus | 1 | 2013 | 3 | 0.100 |
Why?
|
| Sendai virus | 1 | 2013 | 10 | 0.100 |
Why?
|
| Dihydrotestosterone | 1 | 2012 | 17 | 0.100 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 89 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 210 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2012 | 588 | 0.100 |
Why?
|
| Interleukin-1alpha | 1 | 2011 | 24 | 0.100 |
Why?
|
| Vibrio cholerae | 1 | 2011 | 17 | 0.090 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 550 | 0.090 |
Why?
|
| Th1 Cells | 1 | 2011 | 174 | 0.090 |
Why?
|
| Toll-Like Receptor 2 | 3 | 2005 | 219 | 0.090 |
Why?
|
| Adjuvants, Immunologic | 1 | 2011 | 224 | 0.090 |
Why?
|
| Receptors, Complement | 1 | 2010 | 17 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2013 | 391 | 0.090 |
Why?
|
| Erythrocyte Membrane | 1 | 2010 | 23 | 0.090 |
Why?
|
| Ligands | 2 | 2008 | 411 | 0.080 |
Why?
|
| Pneumococcal Infections | 1 | 2010 | 35 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2011 | 621 | 0.080 |
Why?
|
| Pregnancy | 1 | 2017 | 2215 | 0.080 |
Why?
|
| Base Sequence | 3 | 2015 | 1302 | 0.080 |
Why?
|
| Transplantation, Heterologous | 2 | 2020 | 223 | 0.080 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2020 | 52 | 0.080 |
Why?
|
| Drosophila melanogaster | 1 | 2013 | 481 | 0.080 |
Why?
|
| Interleukin-6 | 3 | 2005 | 309 | 0.080 |
Why?
|
| Sex Factors | 1 | 2012 | 935 | 0.080 |
Why?
|
| Interleukin-8 | 2 | 2006 | 87 | 0.080 |
Why?
|
| Interleukin-23 | 1 | 2009 | 19 | 0.080 |
Why?
|
| beta-Glucans | 1 | 2009 | 54 | 0.080 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2009 | 44 | 0.080 |
Why?
|
| Virulence | 2 | 2007 | 188 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 1 | 2009 | 85 | 0.080 |
Why?
|
| Adenoviridae | 1 | 2009 | 117 | 0.070 |
Why?
|
| Neutrophil Activation | 1 | 2008 | 24 | 0.070 |
Why?
|
| RNA, Small Interfering | 2 | 2023 | 858 | 0.070 |
Why?
|
| RNA Helicases | 1 | 2009 | 88 | 0.070 |
Why?
|
| Lipopolysaccharides | 1 | 2011 | 627 | 0.070 |
Why?
|
| Binding Sites | 3 | 2017 | 881 | 0.070 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 73 | 0.070 |
Why?
|
| Macrolides | 1 | 2008 | 37 | 0.070 |
Why?
|
| Erythrocytes | 1 | 2009 | 146 | 0.070 |
Why?
|
| Mice, Transgenic | 3 | 2020 | 1206 | 0.070 |
Why?
|
| DNA, Fungal | 1 | 2008 | 58 | 0.070 |
Why?
|
| Infant | 1 | 2012 | 1493 | 0.070 |
Why?
|
| Virus Internalization | 1 | 2008 | 81 | 0.070 |
Why?
|
| Chemokines | 2 | 2008 | 93 | 0.070 |
Why?
|
| Rhabdoviridae Infections | 1 | 2007 | 5 | 0.070 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2007 | 17 | 0.070 |
Why?
|
| Risk Factors | 1 | 2017 | 4990 | 0.070 |
Why?
|
| Receptors, Fc | 1 | 2007 | 21 | 0.070 |
Why?
|
| Caenorhabditis elegans | 1 | 2013 | 623 | 0.070 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2007 | 32 | 0.070 |
Why?
|
| CpG Islands | 1 | 2008 | 211 | 0.070 |
Why?
|
| Virus Activation | 1 | 2006 | 23 | 0.070 |
Why?
|
| Time Factors | 2 | 2020 | 3621 | 0.070 |
Why?
|
| Viral Fusion Proteins | 1 | 2006 | 54 | 0.060 |
Why?
|
| Young Adult | 2 | 2020 | 4274 | 0.060 |
Why?
|
| Proteins | 1 | 2011 | 730 | 0.060 |
Why?
|
| Hospitalization | 2 | 2024 | 1293 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2006 | 450 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2012 | 3072 | 0.060 |
Why?
|
| Leukotriene Antagonists | 1 | 2024 | 8 | 0.060 |
Why?
|
| Moloney murine leukemia virus | 1 | 2024 | 17 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 2015 | 1469 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1055 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2009 | 541 | 0.060 |
Why?
|
| Encephalitis, Viral | 1 | 2004 | 5 | 0.060 |
Why?
|
| STAT1 Transcription Factor | 1 | 2003 | 35 | 0.050 |
Why?
|
| Respiratory Burst | 1 | 2003 | 20 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2005 | 238 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2005 | 645 | 0.050 |
Why?
|
| NADPH Oxidases | 1 | 2003 | 67 | 0.050 |
Why?
|
| Ribosomal Proteins | 1 | 2003 | 41 | 0.050 |
Why?
|
| Outpatients | 1 | 2024 | 137 | 0.050 |
Why?
|
| Abatacept | 1 | 2023 | 64 | 0.050 |
Why?
|
| Length of Stay | 1 | 2017 | 779 | 0.050 |
Why?
|
| Hyphae | 2 | 2015 | 15 | 0.050 |
Why?
|
| Infliximab | 1 | 2023 | 49 | 0.050 |
Why?
|
| Autoimmune Diseases | 1 | 2024 | 220 | 0.050 |
Why?
|
| Protein Binding | 2 | 2017 | 1555 | 0.050 |
Why?
|
| Stem Cells | 1 | 2024 | 255 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2003 | 212 | 0.050 |
Why?
|
| Electron Microscope Tomography | 1 | 2022 | 15 | 0.050 |
Why?
|
| Singapore | 1 | 2021 | 9 | 0.050 |
Why?
|
| Japan | 1 | 2021 | 51 | 0.050 |
Why?
|
| Mexico | 1 | 2021 | 39 | 0.050 |
Why?
|
| Republic of Korea | 1 | 2021 | 29 | 0.050 |
Why?
|
| Coronavirus | 1 | 2021 | 12 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2023 | 215 | 0.050 |
Why?
|
| Gene Expression | 2 | 2017 | 810 | 0.050 |
Why?
|
| Bronchi | 1 | 2021 | 82 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2021 | 133 | 0.040 |
Why?
|
| Procainamide | 1 | 2020 | 6 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2022 | 187 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 178 | 0.040 |
Why?
|
| Equipment Design | 1 | 2021 | 330 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2021 | 584 | 0.040 |
Why?
|
| Cloning, Molecular | 2 | 2017 | 381 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 91 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 451 | 0.040 |
Why?
|
| Macaca mulatta | 1 | 2020 | 228 | 0.040 |
Why?
|
| Complement C3 | 1 | 2019 | 59 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2019 | 190 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 88 | 0.040 |
Why?
|
| Polymorphism, Genetic | 2 | 2016 | 185 | 0.040 |
Why?
|
| Graft Survival | 1 | 2019 | 290 | 0.040 |
Why?
|
| RNA Folding | 1 | 2018 | 6 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2019 | 126 | 0.040 |
Why?
|
| Orthomyxoviridae | 1 | 2017 | 26 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2017 | 100 | 0.040 |
Why?
|
| Glucose | 1 | 2020 | 445 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2017 | 83 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2018 | 235 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2017 | 356 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2017 | 288 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2017 | 1555 | 0.030 |
Why?
|
| Zanamivir | 1 | 2016 | 5 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2017 | 253 | 0.030 |
Why?
|
| Swine | 1 | 2018 | 355 | 0.030 |
Why?
|
| Phylogeny | 1 | 2018 | 337 | 0.030 |
Why?
|
| Tuberculosis | 1 | 2020 | 270 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 1 | 2016 | 100 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2017 | 424 | 0.030 |
Why?
|
| Hydrogen Bonding | 1 | 2016 | 125 | 0.030 |
Why?
|
| Thermodynamics | 1 | 2016 | 191 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2016 | 248 | 0.030 |
Why?
|
| Static Electricity | 1 | 2016 | 163 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2020 | 845 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2016 | 119 | 0.030 |
Why?
|
| Insulin | 1 | 2019 | 673 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2016 | 333 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 587 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2015 | 46 | 0.030 |
Why?
|
| Genes, Viral | 1 | 2015 | 56 | 0.030 |
Why?
|
| Chemokine CCL2 | 2 | 2007 | 54 | 0.030 |
Why?
|
| Influenza A Virus, H1N2 Subtype | 1 | 2015 | 6 | 0.030 |
Why?
|
| Point Mutation | 1 | 2015 | 160 | 0.030 |
Why?
|
| Nucleoproteins | 1 | 2015 | 32 | 0.030 |
Why?
|
| Limit of Detection | 1 | 2015 | 43 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2015 | 89 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2015 | 118 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2015 | 106 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1995 | 41 | 0.030 |
Why?
|
| Tripartite Motif Proteins | 1 | 2014 | 39 | 0.030 |
Why?
|
| Receptors, Complement 3b | 1 | 2014 | 12 | 0.030 |
Why?
|
| Genetic Drift | 1 | 2014 | 16 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 226 | 0.030 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2014 | 90 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2014 | 110 | 0.030 |
Why?
|
| Models, Biological | 1 | 2019 | 1143 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 264 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 205 | 0.030 |
Why?
|
| HIV Infections | 1 | 2020 | 914 | 0.030 |
Why?
|
| Genotype | 1 | 2015 | 619 | 0.030 |
Why?
|
| Computational Biology | 1 | 2015 | 334 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2014 | 554 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2014 | 377 | 0.020 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2014 | 250 | 0.020 |
Why?
|
| Paneth Cells | 1 | 2011 | 5 | 0.020 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2011 | 21 | 0.020 |
Why?
|
| Gliotoxin | 1 | 2011 | 4 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 1368 | 0.020 |
Why?
|
| Duodenum | 1 | 2011 | 42 | 0.020 |
Why?
|
| Child | 1 | 2020 | 4201 | 0.020 |
Why?
|
| Autoantigens | 1 | 2011 | 129 | 0.020 |
Why?
|
| Inflammasomes | 1 | 2014 | 324 | 0.020 |
Why?
|
| Streptococcus pneumoniae | 1 | 2010 | 63 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 1995 | 674 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2014 | 697 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 851 | 0.020 |
Why?
|
| Cell Survival | 1 | 2011 | 559 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 5126 | 0.020 |
Why?
|
| Metalloendopeptidases | 1 | 2009 | 22 | 0.020 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2009 | 25 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2010 | 260 | 0.020 |
Why?
|
| United States | 1 | 2021 | 7432 | 0.020 |
Why?
|
| DNA-Cytosine Methylases | 1 | 2008 | 3 | 0.020 |
Why?
|
| Mannose-Binding Lectins | 1 | 2008 | 21 | 0.020 |
Why?
|
| Cell Compartmentation | 1 | 2008 | 35 | 0.020 |
Why?
|
| Hybridomas | 1 | 2008 | 64 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2008 | 34 | 0.020 |
Why?
|
| Endonucleases | 1 | 2008 | 80 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2008 | 171 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2011 | 695 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2007 | 157 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 2007 | 157 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2009 | 418 | 0.020 |
Why?
|
| Herpesvirus 2, Human | 1 | 2005 | 10 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2007 | 743 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 986 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2004 | 339 | 0.010 |
Why?
|
| Age Factors | 1 | 2005 | 1505 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2005 | 1286 | 0.010 |
Why?
|
| Glycogen Synthase | 1 | 1995 | 4 | 0.010 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 1995 | 10 | 0.010 |
Why?
|
| Protein Phosphatase 1 | 1 | 1995 | 16 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1995 | 148 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1995 | 164 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1995 | 128 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1995 | 496 | 0.010 |
Why?
|
| Biopsy | 1 | 1995 | 410 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 1953 | 0.010 |
Why?
|